Clinical Trial Update: Single Versus Double Dose Intra-vaginal Prostaglandin E2 "Misoprostol" Prior Abdominal Myomectomy [Phase 4]

View source ↗

Summary

A Phase 4 study comparing single-dose versus double-dose intra-vaginal misoprostol (prostaglandin E2) given prior to abdominal myomectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Mansoura University | Conditions: Prostaglandin E2 "Misoprostol" Prior Abdominal Myomectomy | Phase 4 | Status: COMPLETED